Brompheniramine Maleate is an antihistamine medication commonly used to alleviate
allergy symptoms. It is marketed under several trade names, including Dimetapp,
Bromfed, and others. This medication belongs to a class of drugs known as first-generation antihistamines, which are typically characterized by their ability to cross the blood-brain barrier and potentially cause sedation. Researchers and pharmaceutical companies have long studied Brompheniramine Maleate, particularly because of its effectiveness in treating symptoms such as
runny nose,
sneezing,
itching, and
watery eyes often associated with allergic reactions and the
common cold.
Brompheniramine Maleate has been approved for use in various formulations, including tablets, syrups, and extended-release capsules. Its primary indication is for the temporary relief of symptoms caused by
hay fever or other
upper respiratory allergies. Over time, the drug has shown promise in treating additional conditions, such as itching and
swelling caused by skin reactions, though these are not its primary uses. Research institutions continue to explore its full potential, aiming to enhance its efficacy and minimize side effects.
Brompheniramine Maleate works by targeting
histamine H1 receptors in the body. Histamine is a substance produced by the body during allergic reactions, leading to symptoms such as itching, swelling, and
redness. By blocking these receptors, Brompheniramine Maleate prevents histamine from binding to them, thereby reducing the allergic symptoms. This antagonistic action on
H1 receptors makes it particularly effective in alleviating the discomfort associated with histamine release during allergic reactions. Additionally, Brompheniramine Maleate can exert mild anticholinergic effects, which contribute to drying up nasal secretions and reducing
nasal congestion.
How to use Brompheniramine Maleate varies depending on the specific product and formulation. For immediate relief, it is often taken orally in the form of tablets or syrup. The typical dosage for adults and children over the age of 12 is 4 mg every 4 to 6 hours, not exceeding 24 mg in a 24-hour period. For children aged 6 to 12, the dosage is generally lower, about 2 mg every 4 to 6 hours, without exceeding 12 mg in a 24-hour period. It's crucial to follow the dosage instructions provided by a healthcare provider or those listed on the product's label.
Extended-release capsules offer a more convenient dosing schedule, as they are usually taken once or twice daily, depending on the specific product. The onset of action for Brompheniramine Maleate is typically within 1 to 2 hours after oral administration, with peak effects occurring within 5 to 6 hours. The duration of action usually lasts approximately 12 hours, which makes it effective for managing symptoms throughout the day or night.
Like all medications, Brompheniramine Maleate comes with potential side effects. Common side effects include
drowsiness,
dizziness,
dry mouth, blurred vision,
constipation, and
urinary retention. These effects are primarily due to its ability to cross the blood-brain barrier and its anticholinergic properties. While these side effects can be bothersome, they are generally mild and tend to diminish with continued use as the body adjusts to the medication.
However, there are more severe side effects that require immediate medical attention. These include
rapid or irregular heartbeat, severe dizziness or
fainting,
mental or mood changes (such as
confusion), and signs of an allergic reaction (such as
rash, itching, swelling, severe dizziness, and
trouble breathing). It is essential to consult a healthcare provider if any of these severe side effects occur.
There are also specific contraindications for the use of Brompheniramine Maleate. It should not be used in individuals with a known hypersensitivity to the medication or any of its components. Additionally, it should be used with caution in patients with conditions such as
asthma,
glaucoma,
peptic ulcer, urinary retention, or enlarged prostate, as it may exacerbate these conditions.
Brompheniramine Maleate can interact with other medications, which may either diminish its efficacy or increase the risk of adverse effects. For instance, using it concurrently with other central nervous system depressants, such as alcohol, benzodiazepines, or opioids, can enhance drowsiness and dizziness.
Monoamine oxidase inhibitors (MAOIs), a type of antidepressant, can also interact negatively with Brompheniramine Maleate and should be avoided. MAOIs can prolong and intensify the anticholinergic effects of antihistamines, leading to severe side effects.
Moreover, other medications with anticholinergic properties, such as certain antidepressants and antipsychotics, can compound the anticholinergic effects of Brompheniramine Maleate, increasing the risk of side effects like dry mouth, constipation, and urinary retention. It's crucial to inform healthcare providers about all medications, including over-the-counter drugs and herbal supplements, to avoid potential interactions.
In conclusion, Brompheniramine Maleate is a well-established antihistamine that effectively relieves allergy symptoms. While it is generally safe and effective when used as directed, it is important to be aware of its potential side effects and interactions with other medications. Always consult a healthcare provider before starting or combining it with other treatments to ensure it is used safely and effectively.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


